The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
Farhad Imam*, Rowan Saloner, Jacob W. Vogel, Varsha Krish, Gamal Abdel-Azim, Muhammad Ali, Lijun An, Federica Anastasi, David Bennett, Alexa Pichet Binette, Adam L. Boxer, Martin Bringmann, Jeffrey M. Burns, Carlos Cruchaga, Jeff L. Dage, Amelia Farinas, Luigi Ferrucci, Caitlin A. Finney, Mark Frasier, Oskar HanssonTimothy J. Hohman, Erik C. B. Johnson, Mika Kivimaki, Roxanna Korologou-Linden, Agustin Ruiz Laza, Allan I. Levey, Inga Liepelt-Scarfone, Lina Lu, Niklas Mattsson-Carlgren, Lefkos T. Middleton, Kwangsik Nho, Hamilton Se-Hwee Oh, Ronald C. Petersen, Eric M. Reiman, Oliver Robinson, Jeffrey D. Rothstein, Andrew J. Saykin, Artur Shvetcov, Chad Slawson, Bart Smets, Marc Suarez-Calvet, Betty M. Tijms, Maarten Timmers, Fernando Vieira, Natalia Vilor-Tejedor, Pieter Jelle Visser, Keenan A. Walker, Laura M. Winchester, Tony Wyss-Coray, Chengran Yang, Global Neurodegeneration Proteomics Consortium GNPC
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging'. Together they form a unique fingerprint.